Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
General Montana
Archived
•
August 24, 2026
•
SEONGNAM, South Korea, Aug. 23, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California.
Source: Missoulian MT | https://missoulian.com/search/?f=rss&t=article&l=50&s=start_time&sd=desc - Read Original
"Commision Art Work or Just pure Beauty."
"What you put in is not always what you get out."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"We build AI or anything ICST"
